Hedge Fund - Chescapmanager LLC
Cara Therapeutics Inc. (CARA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $3.63 |
| 2 | 2024 - Q3 (2024-09-30) | $524,250 | 0.05% | 47,280.833,333,333 | $3.91 |
| 3 | 2024 - Q2 (2024-06-30) | $439,144 | 0.03% | 47,280.833,333,333 | $7.95 |
| 4 | 2024 - Q1 (2024-03-31) | $1,548,920 | 0.15% | 47,280.833,333,333 | $8.64 |
| 5 | 2023 - Q4 (2023-12-31) | $1,301,819 | 0.12% | 48,669.777,777,778 | $13.80 |
| 6 | 2023 - Q3 (2023-09-30) | $2,951,142 | 0.37% | 48,795.333,333,333 | $31.27 |
| 7 | 2023 - Q2 (2023-06-30) | $4,685,280 | 0.72% | 45,988.222,222,222 | $45.92 |
| 8 | 2023 - Q1 (2023-03-31) | $5,698 | 0.89% | 32,233.111,111,111 | $111.63 |
| 9 | 2022 - Q4 (2022-12-31) | $12,463 | 2.92% | 32,233.111,111,111 | $126.60 |
| 10 | 2022 - Q3 (2022-09-30) | $10,861,000 | 2.53% | 32,233.111,111,111 | $120.74 |
| 11 | 2022 - Q2 (2022-06-30) | $10,594,000 | 2.5% | 32,233.111,111,111 | $116.94 |
| 12 | 2022 - Q1 (2022-03-31) | $14,281,000 | 1.93% | 32,649.777,777,778 | $136.83 |
| 13 | 2021 - Q4 (2021-12-31) | $15,894,000 | 2.12% | 36,247.305,555,556 | $167.49 |
| 14 | 2021 - Q3 (2021-09-30) | $20,161,000 | 2.85% | 36,247.305,555,556 | $167.23 |
| 15 | 2021 - Q2 (2021-06-30) | $18,617,000 | 2.04% | 36,238.972,222,222 | $211.23 |
| 16 | 2021 - Q1 (2021-03-31) | $28,540,000 | 3.04% | 36,516.75 | $228.20 |
| 17 | 2020 - Q4 (2020-12-31) | $19,890,000 | 2.42% | 36,516.75 | $174.73 |
| 18 | 2020 - Q3 (2020-09-30) | $16,725,000 | 2.7% | 36,508.416,666,667 | $193.63 |
| 19 | 2020 - Q2 (2020-06-30) | $25,382,000 | 4.27% | 41,230.638,888,889 | $184.10 |
| 20 | 2020 - Q1 (2020-03-31) | $17,244,000 | 4.24% | 36,261.361,111,111 | $181.14 |
| 21 | 2019 - Q4 (2019-12-31) | $20,938,000 | 3.07% | 36,102.805,555,556 | $233.91 |
| 22 | 2019 - Q3 (2019-09-30) | $22,707,000 | 3.23% | 34,505.583,333,333 | $277.10 |
| 23 | 2019 - Q2 (2019-06-30) | $23,697,000 | 2.36% | 30,616.694,444,444 | $234.20 |
| 24 | 2019 - Q1 (2019-03-31) | $23,604,000 | 2.8% | 33,418.194,444,444 | $199.53 |
| 25 | 2018 - Q4 (2018-12-31) | $15,661,000 | 3.78% | 33,462.611,111,111 | $215.03 |
| 26 | 2018 - Q3 (2018-09-30) | $28,851,000 | 2.95% | 33,462.611,111,111 | $240.66 |
| 27 | 2018 - Q2 (2018-06-30) | $22,299,000 | 2.57% | 32,345.305,555,556 | $169.44 |
| 28 | 2018 - Q1 (2018-03-31) | $13,035,000 | 1.94% | 29,248.138,888,889 | $161.68 |
| 29 | 2017 - Q4 (2017-12-31) | $12,643,000 | 2.06% | 28,692.583,333,333 | $151.96 |
| 30 | 2017 - Q3 (2017-09-30) | $14,003,000 | 2.72% | 28,413.611,111,111 | $166.92 |
| 31 | 2017 - Q2 (2017-06-30) | $15,673,000 | 2.64% | 28,288.611,111,111 | $211.51 |
| 32 | 2017 - Q1 (2017-03-31) | $16,429,000 | 2.25% | 24,816.388,888,889 | $178.07 |
| 33 | 2016 - Q4 (2016-12-31) | $6,365,000 | 2.33% | 19,032.416,666,667 | $106.97 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:3.0000 on 2025-04-16
-
1.0000:12.0000 on 2024-12-31